These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 22210627)

  • 1. Silencing of multi-copy HPV16 by viral self-methylation and chromatin occlusion: a model for epigenetic virus-host interaction.
    De-Castro Arce J; Göckel-Krzikalla E; Rösl F
    Hum Mol Genet; 2012 Apr; 21(8):1693-705. PubMed ID: 22210627
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Cellular DNA Helicase ChlR1 Regulates Chromatin and Nuclear Matrix Attachment of the Human Papillomavirus 16 E2 Protein and High-Copy-Number Viral Genome Establishment.
    Harris L; McFarlane-Majeed L; Campos-León K; Roberts S; Parish JL
    J Virol; 2017 Jan; 91(1):. PubMed ID: 27795438
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serine/threonine kinases 31(STK31) may be a novel cellular target gene for the HPV16 oncogene E7 with potential as a DNA hypomethylation biomarker in cervical cancer.
    Yin FF; Wang N; Bi XN; Yu X; Xu XH; Wang YL; Zhao CQ; Luo B; Wang YK
    Virol J; 2016 Apr; 13():60. PubMed ID: 27044426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epigenetic silencing of interferon-kappa in human papillomavirus type 16-positive cells.
    Rincon-Orozco B; Halec G; Rosenberger S; Muschik D; Nindl I; Bachmann A; Ritter TM; Dondog B; Ly R; Bosch FX; Zawatzky R; Rösl F
    Cancer Res; 2009 Nov; 69(22):8718-25. PubMed ID: 19887612
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The HPV16 E2 transcriptional regulator mode of action depends on the physical state of the viral genome.
    Schmidt MT; Olejnik AK; Goździcka-Józefiak A
    Acta Biochim Pol; 2005; 52(4):823-32. PubMed ID: 16273126
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of human papillomavirus type 16 early gene expression in trophoblastic and cervical cells.
    Weyn C; Vanderwinden JM; Rasschaert J; Englert Y; Fontaine V
    Virology; 2011 Mar; 412(1):146-55. PubMed ID: 21276600
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High human papillomavirus oncogene mRNA expression and not viral DNA load is associated with poor prognosis in cervical cancer patients.
    de Boer MA; Jordanova ES; Kenter GG; Peters AA; Corver WE; Trimbos JB; Fleuren GJ
    Clin Cancer Res; 2007 Jan; 13(1):132-8. PubMed ID: 17200347
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of cellular differentiation, chromosomal integration and 5-aza-2'-deoxycytidine treatment on human papillomavirus-16 DNA methylation in cultured cell lines.
    Kalantari M; Lee D; Calleja-Macias IE; Lambert PF; Bernard HU
    Virology; 2008 May; 374(2):292-303. PubMed ID: 18242658
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methylation of the long control region of HPV16 is related to the severity of cervical neoplasia.
    Ding DC; Chiang MH; Lai HC; Hsiung CA; Hsieh CY; Chu TY
    Eur J Obstet Gynecol Reprod Biol; 2009 Dec; 147(2):215-20. PubMed ID: 19819061
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The E2F5 repressor is an activator of E6/E7 transcription and of the S-phase entry in HPV18-associated cells.
    Teissier S; Pang CL; Thierry F
    Oncogene; 2010 Sep; 29(36):5061-70. PubMed ID: 20639900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TopBP1 regulates human papillomavirus type 16 E2 interaction with chromatin.
    Donaldson MM; Boner W; Morgan IM
    J Virol; 2007 Apr; 81(8):4338-42. PubMed ID: 17287259
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RNA interference against HPV16 E7 oncogene leads to viral E6 and E7 suppression in cervical cancer cells and apoptosis via upregulation of Rb and p53.
    Sima N; Wang W; Kong D; Deng D; Xu Q; Zhou J; Xu G; Meng L; Lu Y; Wang S; Ma D
    Apoptosis; 2008 Feb; 13(2):273-81. PubMed ID: 18060502
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypomethylated CpG around the transcription start site enables TERT expression and HPV16 E6 regulates TERT methylation in cervical cancer cells.
    Jiang J; Zhao LJ; Zhao C; Zhang G; Zhao Y; Li JR; Li XP; Wei LH
    Gynecol Oncol; 2012 Mar; 124(3):534-41. PubMed ID: 22108635
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclooxygenase-2 transcription is regulated by human papillomavirus 16 E6 and E7 oncoproteins: evidence of a corepressor/coactivator exchange.
    Subbaramaiah K; Dannenberg AJ
    Cancer Res; 2007 Apr; 67(8):3976-85. PubMed ID: 17440114
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Viral interaction: a possible contributing factor in head and neck cancer progression.
    Underbrink MP; Hoskins SL; Pou AM; Albrecht T
    Acta Otolaryngol; 2008; 128(12):1361-9. PubMed ID: 18607925
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Silencing of integrated human papillomavirus-16 oncogenes by small interfering RNA-mediated heterochromatization.
    Palanichamy JK; Mehndiratta M; Bhagat M; Ramalingam P; Das B; Das P; Sinha S; Chattopadhyay P
    Mol Cancer Ther; 2010 Jul; 9(7):2114-22. PubMed ID: 20587668
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TGF-beta1 and IL-4 downregulate human papillomavirus-16 oncogene expression but have differential effects on the malignant phenotype of cervical carcinoma cells.
    Donalisio M; Cornaglia M; Landolfo S; Lembo D
    Virus Res; 2008 Mar; 132(1-2):253-6. PubMed ID: 18206261
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tandemly Integrated HPV16 Can Form a Brd4-Dependent Super-Enhancer-Like Element That Drives Transcription of Viral Oncogenes.
    Dooley KE; Warburton A; McBride AA
    mBio; 2016 Sep; 7(5):. PubMed ID: 27624132
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of HPV-16 E5, E6 and E7 proteins on survival, adhesion, migration and invasion of trophoblastic cells.
    Boulenouar S; Weyn C; Van Noppen M; Moussa Ali M; Favre M; Delvenne PO; Bex F; Noël A; Englert Y; Fontaine V
    Carcinogenesis; 2010 Mar; 31(3):473-80. PubMed ID: 19917629
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence for alteration of EZH2, BMI1, and KDM6A and epigenetic reprogramming in human papillomavirus type 16 E6/E7-expressing keratinocytes.
    Hyland PL; McDade SS; McCloskey R; Dickson GJ; Arthur K; McCance DJ; Patel D
    J Virol; 2011 Nov; 85(21):10999-1006. PubMed ID: 21865393
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.